Search Page

1

Cite

Share

Non-Photoinduced Biological Properties of Verteporfin.

Gibault F, Corvaisier M, Bailly F, Huet G, Melnyk P, Cotelle P. Gibault F, et al. Among authors: corvaisier m. Curr Med Chem. 2016;23(11):1171-84. doi: 10.2174/0929867323666160316125048. Curr Med Chem. 2016. PMID: 26980565 Review.

Cite

Share

2

Cite

Share

γ-Tubulin⁻γ-Tubulin Interactions as the Basis for the Formation of a Meshwork.

Rosselló CA, Lindström L, Eklund G, Corvaisier M, Kristensson MA. Rosselló CA, et al. Among authors: corvaisier m. Int J Mol Sci. 2018 Oct 19;19(10):3245. doi: 10.3390/ijms19103245. Int J Mol Sci. 2018. PMID: 30347727 Free PMC article. Review.

Cite

Share

3

Cite

Share

The γ-tubulin meshwork assists in the recruitment of PCNA to chromatin in mammalian cells.

Corvaisier M, Zhou J, Malycheva D, Cornella N, Chioureas D, Gustafsson NMS, Rosselló CA, Ayora S, Li T, Ekström-Holka K, Jirström K, Lindström L, Alvarado-Kristensson M. Corvaisier M, et al. Commun Biol. 2021 Jun 22;4(1):767. doi: 10.1038/s42003-021-02280-1. Commun Biol. 2021. PMID: 34158617 Free PMC article.

Cite

Share

4

Cite

Share

Non-Canonical Functions of the Gamma-Tubulin Meshwork in the Regulation of the Nuclear Architecture.

Corvaisier M, Alvarado-Kristensson M. Corvaisier M, et al. Cancers (Basel). 2020 Oct 23;12(11):3102. doi: 10.3390/cancers12113102. Cancers (Basel). 2020. PMID: 33114224 Free PMC article. Review.

Cite

Share

5

Cite

Share

Gemcitabine-induced epithelial-mesenchymal transition-like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal-like phenotype.

El Amrani M, Corfiotti F, Corvaisier M, Vasseur R, Fulbert M, Skrzypczyk C, Deshorgues AC, Gnemmi V, Tulasne D, Lahdaoui F, Vincent A, Pruvot FR, Van Seuningen I, Huet G, Truant S. El Amrani M, et al. Among authors: corvaisier m. Mol Carcinog. 2019 Nov;58(11):1985-1997. doi: 10.1002/mc.23090. Epub 2019 Aug 2. Mol Carcinog. 2019. PMID: 31373074

Cite

Share

6

Cite

Share

Toward the Discovery of a Novel Class of YAP⁻TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP⁻TEAD Protein⁻Protein Interface.

Gibault F, Coevoet M, Sturbaut M, Farce A, Renault N, Allemand F, Guichou JF, Drucbert AS, Foulon C, Magnez R, Thuru X, Corvaisier M, Huet G, Chavatte P, Melnyk P, Bailly F, Cotelle P. Gibault F, et al. Among authors: corvaisier m. Cancers (Basel). 2018 May 8;10(5):140. doi: 10.3390/cancers10050140. Cancers (Basel). 2018. PMID: 29738494 Free PMC article.

Cite

Share

7

Cite

Share

Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway.

Gibault F, Bailly F, Corvaisier M, Coevoet M, Huet G, Melnyk P, Cotelle P. Gibault F, et al. Among authors: corvaisier m. ChemMedChem. 2017 Jun 21;12(12):954-961. doi: 10.1002/cmdc.201700063. Epub 2017 Apr 20. ChemMedChem. 2017. PMID: 28334506

Cite

Share

8

Cite

Share

Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse.

Corvaisier M, Bauzone M, Corfiotti F, Renaud F, El Amrani M, Monté D, Truant S, Leteurtre E, Formstecher P, Van Seuningen I, Gespach C, Huet G. Corvaisier M, et al. Oncotarget. 2016 Aug 30;7(35):56699-56712. doi: 10.18632/oncotarget.11057. Oncotarget. 2016. PMID: 27527859 Free PMC article.

Cite

Share

9

Cite

Share

Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis.

Touil Y, Igoudjil W, Corvaisier M, Dessein AF, Vandomme J, Monté D, Stechly L, Skrypek N, Langlois C, Grard G, Millet G, Leteurtre E, Dumont P, Truant S, Pruvot FR, Hebbar M, Fan F, Ellis LM, Formstecher P, Van Seuningen I, Gespach C, Polakowska R, Huet G. Touil Y, et al. Among authors: corvaisier m. Clin Cancer Res. 2014 Feb 15;20(4):837-46. doi: 10.1158/1078-0432.CCR-13-1854. Epub 2013 Dec 9. Clin Cancer Res. 2014. PMID: 24323901 Free PMC article.

Cite

Share